健脾消癌方对结肠癌HCT116细胞迁移、侵袭的影响研究  被引量:9

Effect of Jianpi Xiaoai Prescription on Migration and Invasion of Colorectal Cancer HCT116 Cells

在线阅读下载全文

作  者:简小兰[1,2] 曾普华 杜佳[3] 何凤姣 李克雄[3] 蒋益兰[1,2] JIAN Xiaolan;ZENG Puhua;DU Jia;HE Fengjiao;LI Kexiong;JIANG Yilan(The Affiliated Hospital of Hunan Academy of Chinese Medicine,Changsha Hunan China 410006;Hunan Key Laboratory of Chinese Medicine Oncology,Changsha Hunan China 410006;Hunan University of Chinese Medic ine,Changsha Hunan China 410208)

机构地区:[1]湖南省中医药研究院附属医院,湖南长沙410006 [2]中医肿瘤学湖南省重点实验室,湖南长沙410006 [3]湖南中医药大学,湖南长沙410208

出  处:《中医学报》2021年第1期132-137,共6页Acta Chinese Medicine

基  金:国家自然科学基金项目(81904109);中央引导地方科技发展专项资金项目——抗肿瘤中药创新平台建设项目(2018CT5005);湖南省自然科学基金项目(2019JJ50344);湖南省中医药研究院重点项目(201802)。

摘  要:目的:研究健脾消癌方含药血清对HCT116细胞迁移、侵袭的影响,并初步探讨其机制。方法:10%、15%、20%的健脾消癌方含药血清处理HCT116细胞,划痕实验、Transwell侵袭实验检测细胞迁移及侵袭能力,Western blot检测细胞内基质金属蛋白酶2(matrix metalloproteinase-2,MMP-2)、基质金属蛋白酶9(matrix metalloproteinase-9,MMP-9)的表达。结果:处理24 h、48 h,与相同浓度鼠血清对照组相比,10%、15%、20%的含药血清组划痕距离均增宽(P<0.05,P<0.01);与相同浓度鼠血清对照组相比,10%、15%、20%的含药血清组的迁移抑制率及侵袭抑制率均明显增大(P<0.05),均与浓度正相关。与15%的鼠血清对照组比较,15%的含药血清组MMP-2、MMP-9蛋白表达显著下调(P<0.01)。结论:健脾消癌方抗复发转移机制可能是通过下调MMP-2、MMP-9蛋白表达,从而抑制HCT116细胞迁移、侵袭。Objective:To study the effect of Jianpi Xiaoai Prescription drug containing serum on the migration and invasion of HCT116 cells,and to explore its mechanism.Methods:HCT116 cells were treated with 10%,15%and 20%Jianpi Xiaoai Prescription drug containing serum.Cell migration and invasion were detected by scratch test and Transwell invasion test.The expression of matrix metalloproteinase-2(MMP-2)and matrix metalloproteinase-9(MMP-9)were detected by Western blot.Results:After 24 h and 48 h treatment,the scratch distance of 10%,15%,20%drug containing serum group was wider than that of the control group(P<0.05,P<0.01);compared with the control group,the migration inhibition rate and invasion inhibition rate of 10%,15%,20%drug containing serum group were significantly increased(P<0.05),and were positively correlated with the concentration;compared with the control group,the expression of MMP-2 and MMP-9 in the 15%drug containing serum group was significantly decreased(P<0.01).Conclusion:The anti recurrence and metastasis mechanism of Jianpi Xiaoai Prescription may be through down regulating the expression of MMP-2 and MMP-9,thus inhibiting the migration and invasion of HCT116 cells.

关 键 词:健脾消癌方 结直肠癌 细胞迁移 侵袭 基质金属蛋白酶2 基质金属蛋白酶9 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象